...Good morning, everyone. So thanks for joining today. We're excited to be here at ASH. Really exciting agenda today to walk through. And I'll start by making some opening remarks, and then we'll turn it over to our four esteemed thought leaders and PIs on our clinical trials. We're excited to have them here today, and I'll introduce them. So these are the doctors, who have been working on our trials and helping us advance our programs for quite some time and making a difference for patients. First, in order, Dr. DeFilipp at MGH. Sorry, it's a little delayed here. So here we are at the agenda. Right. So we'll start off with Dr. DeFilipp. He's the Director of Bone Marrow Transplant Clinical Research at MGH. He'll talk about the latest data in chronic GVHD that we're presenting here today this weekend. And then Nick is going to lead us in a panel discussion with him where we'll be able to ask questions. There will be Q&A from the audience as well. And then we'll turn it to Revuforj where we'll...
